HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
2007
18201	18201 Montalto MC, Farrar G, Hehir CT Fibrillar and oligomeric beta-amyloid as distinct local biomarkers for Alzheimer's disease IMAGING AND THE AGING BRAIN. 2007; 1097: 239-258	0	9	26	95
18202	18202 Thomale UW, Bender M, Casalis P, Rupprecht S, Griebenow M, et al. Tacrolimus depresses local immune cell infiltration but fails to reduce cortical contusion volume in brain-injured rats IMMUNOBIOLOGY. 2007; 212 (7): 567-576	2	8	12	52
18203	18203 Fletcher PT, Powell S, Foster NL, Joshi SC Quantifying metabolic asymmetry modulo structure in Alzheimer's disease INFORMATION PROCESSING IN MEDICAL IMAGING, PROCEEDINGS. 2007; 4584: 446-457	0	0	1	15
18204	18204 Gogos JA Schizophrenia susceptibility genes: In search of a molecular logic and novel drug targets for a devastating disorder INTEGRATING THE NEUROBIOLOGY OF SCHIZOPHRENIA. 2007; 78: 397-422	0	7	5	128
18205	18205 Ricchelli F, Fusi P, Tortora P, Valtorta M, Riva M, et al. Destabilization of non-pathological variants of ataxin-3 by metal ions results in aggregation/fibrillogenesis INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. 2007; 39 (5): 966-977	3	6	28	73
18206	18206 Sode K, Ochiai S, Kobayashi N, Usuzaka E Effect of reparation of repeat sequences in the human alpha-synuclein on fibrillation ability INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES. 2007; 3 (1): 1-7	4	5	12	20
18207	18207 Luo GR, Chen S, Le WD Are heat shock proteins therapeutic target for Parkinson's disease? INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES. 2007; 3 (1): 20-26	3	8	32	69
18208	18208 Han NLR, Wen J, Lin QS, Tan PL, Liou YC, et al. Proteomics analysis of the expression of neurogranin in murine neuroblastoma (Neuro-2a) cells reveals its involvement for cell differentiation INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES. 2007; 3 (5): 263-273	0	1	2	50
18209	18209 Tan U The psychomotor theory of human mind INTERNATIONAL JOURNAL OF NEUROSCIENCE. 2007; 117 (8): 1109-1148	0	1	4	134
18210	18210 Tarlac V, Turnbull V, Stefani D, Kelly L, Walsh R, et al. Inclusion formation by ataxins-1,-2,-3, and-7 INTERNATIONAL JOURNAL OF NEUROSCIENCE. 2007; 117 (9): 1289-1314	0	0	29	55
#	Date / Author / Journal	LCS	GCS	LCR	CR
18211	18211 Mariani E, Monastero R, Mecocci P Mild cognitive impairment: A systematic review JOURNAL OF ALZHEIMERS DISEASE. 2007; 12 (1): 23-35	6	39	20	130
18212	18212 Serretti A, Olgiati P, De Ronchi D Genetics of Alzheimer's disease. A rapidly evolving field JOURNAL OF ALZHEIMERS DISEASE. 2007; 12 (1): 73-92	4	24	18	298
18213	18213 Gruenblatt E, Zander N, Bartl J, Jie L, Monoranu CM, et al. Comparison analysis of gene expression patterns between sporadic Alzheimer's and Parkinson's disease JOURNAL OF ALZHEIMERS DISEASE. 2007; 12 (4): 291-311	0	0	24	87
18214	18214 Takshima A Study of aluminum on the pathology of Alzheimer's disease: In vitro versus in vivo evidence JOURNAL OF ALZHEIMERS DISEASE. 2007; 12 (4): 317-318	0	0	3	5
18215	18215 Barrantes A, Rejas MT, Benitez MJ, Jimenez JS Interaction between Alzheimer's a beta 1-42 peptide and DNA detected by surface plasmon resonance JOURNAL OF ALZHEIMERS DISEASE. 2007; 12 (4): 345-355	2	4	14	50
18216	18216 Luna-Munoz J, Chavez-Macias L, Garcia-Sierra F, Mena R Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer's disease JOURNAL OF ALZHEIMERS DISEASE. 2007; 12 (4): 365-375	12	18	25	46
18217	18217 Tremblay C, Pilote M, Phivilay A, Emond V, Bennett DA, et al. Biochemical characterization of A beta and tau pathologies in mild cognitive impairment and Alzheimer's disease JOURNAL OF ALZHEIMERS DISEASE. 2007; 12 (4): 377-390	5	12	24	53
18218	18218 Becker JS, Zoriy M, Becker JS, Dobrowolska J, Matusch A Laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) in elemental imaging of biological tissues and in proteomicsw JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY. 2007; 22 (7): 736-744	0	43	3	57
18219	18219 Becker JS, Przybylski M Studies of structure and phosphorylation of tau protein using high resolution mass spectrometry JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY. 2007; 22 (7): 761-765	0	1	11	25
18220	18220 Levy S, McConville M, Lazaro GA, Averback P Competitive ELISA studies of neural thread protein in urine in Alzheimer's disease JOURNAL OF CLINICAL LABORATORY ANALYSIS. 2007; 21 (1): 24-33	1	4	7	33
#	Date / Author / Journal	LCS	GCS	LCR	CR
18221	18221 Matsuoka Y, Gray AJ, Hirata-Fukae C, Minami SS, Waterhouse EG, et al. Intranasal NAP administration reduces accumulation of amyloid peptide and tau hyperphosphorylation in a transgenic mouse model of Alzheimer's disease at early pathological stage JOURNAL OF MOLECULAR NEUROSCIENCE. 2007; 31 (2): 165-170	17	38	11	34
18222	18222 Musiek ES, McLaughlin B, Morrow JD Electrophilic cyclopentenone isoprostanes in neurodegeneration JOURNAL OF MOLECULAR NEUROSCIENCE. 2007; 33 (1): 80-86	1	7	18	64
18223	18223 Montine TJ, Quinn J, Kaye J, Morrow JD F-2-isoprostanes as biomarkers of late-onset Alzheimer's disease JOURNAL OF MOLECULAR NEUROSCIENCE. 2007; 33 (1): 114-119	9	15	20	51
18224	18224 Mollenhauer B, Bibl M, Esselmann H, Steinacker P, Trenkwalder C, et al. Tauopathies and synucleinopathies: Do cerebrospinal fluid beta-amyloid peptides reflect disease-specific pathogenesis? JOURNAL OF NEURAL TRANSMISSION. 2007; 114 (7): 919-927	5	7	26	69
18225	18225 Jellinger KA Morphological substrates of parkinsonism with and without dementia: a retrospective clinico-pathological study JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2007; (72): 91-104	6	11	84	168
18226	18226 Offen D, Barhum Y, Levy YS, Burshtein A, Panet H, et al. Intrastriatal transplantation of mouse bone marrow-derived stem cells improves motor behavior in a mouse model of Parkinson's disease JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2007; (72): 133-143	3	9	12	66
18227	18227 Muller N, Schwarz MJ The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2007; (72): 269-280	0	17	5	120
18228	18228 Nudrnamud-Thanoi S, Piyabhan P, Harte MK, Cahir M, Reynolds GP Deficits of neuronal glutamatergic markers in the caudate nucleus in schizophrenia JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2007; (72): 281-285	0	0	4	35
18229	18229 Schwartz L, Civitello L, Dunn-Pirio A, Ryschkewitsch S, Berry E, et al. Evidence of human immunodeficiency virus type 1 infection of nestin- positive neural progenitors in archival pediatric brain tissue JOURNAL OF NEUROVIROLOGY. 2007; 13 (3): 274-283	0	11	9	58
18230	18230 Cueille N, Blanc CT, Riederer IM, Riederer BM Microtubule-associated protein 1B binds glyceraldehyde-3-phosphate dehydrogenase JOURNAL OF PROTEOME RESEARCH. 2007; 6 (7): 2640-2647	1	14	10	59
#	Date / Author / Journal	LCS	GCS	LCR	CR
18231	18231 Krewski D, Yokel RA, Nieboer E, Borchelt D, Cohen J, et al. Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS. 2007; 10: 1-269	3	18	34	1515
18232	18232 Hachiya NS, Kaneko K Investigation of laser-micro dissected inclusion bodies LASER MANIPULATION OF CELLS AND TISSUES. 2007; 82: 355-375	0	0	9	33
18233	18233 Barbas H Specialized elements of orbitofrontal cortex in primates LINKING AFFECT TO ACTION: CRITICAL CONTRIBUTIONS OF THE ORBITOFRONTAL CORTEX. 2007; 1121: 10-32	0	20	14	119
18234	18234 Viskontas IV, Possin KL, Miller BL Symptoms of frontotemporal dementia provide insights into orbitofrontal cortex function and social behavior LINKING AFFECT TO ACTION: CRITICAL CONTRIBUTIONS OF THE ORBITOFRONTAL CORTEX. 2007; 1121: 528-545	4	16	11	83
18235	18235 Dhikav V, Anand KS Glucocorticoids may initiate Alzheimer's disease: A Potential therapeutic role for mifepristone (RU-486) MEDICAL HYPOTHESES. 2007; 68 (5): 1088-1092	0	11	2	32
18236	18236 Pedersen AE The potential for induction of autoimmune disease by a randomly-mutated self-antigen MEDICAL HYPOTHESES. 2007; 68 (6): 1240-1246	0	0	2	67
18237	18237 Stommel EW, Graber D, Montanye J, Cohen JA, Harris BT Does treating schizophrenia reduce the chances of developing amyotrophic lateral sclerosis? MEDICAL HYPOTHESES. 2007; 69 (5): 1021-1028	0	1	13	108
18238	18238 Chaudhuri A, Hollands P, Bhattacharya N Placental umbilical cord blood transfusion in acute ischaemic stroke MEDICAL HYPOTHESES. 2007; 69 (6): 1267-1271	1	1	7	32
18239	18239 Cacabelos R Molecular pathology and pharmacogenomics in Alzheimer's disease: Polygenic-related effects of multifactorial treatments on cognition, anxiety, and depression METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY. 2007; 29: 1-91	1	8	100	677
18240	18240 Brignull HR, Morley JF, Morimoto RI The stress of misfolded proteins: C-elegans models for neurodegenerative disease and aging MOLECULAR ASPECTS OF THE STRESS RESPONSE: CHAPERONES, MEMBRANES AND NETWORKS. 2007; 594: 167-189	1	23	25	104
#	Date / Author / Journal	LCS	GCS	LCR	CR
18241	18241 Rankin CA, Sun Q, Gamblin TC Tau phosphorylation by GSK-3 beta promotes tangle-like filament morphology MOLECULAR NEURODEGENERATION. 2007; 2: Art. No. 12	5	13	40	53
18242	18242 Casadesus G, Smith MA, Basu S, Hua J, Capobianco DE, et al. Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer disease MOLECULAR NEURODEGENERATION. 2007; 2: Art. No. 2	8	19	18	58
18243	18243 Gu XF, Andre VM, Cepeda C, Li SH, Li XJ, et al. Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease MOLECULAR NEURODEGENERATION. 2007; 2: Art. No. 8	5	19	8	51
18244	18244 Cole GM, Teter B, Frautschy SA Neuroprotective effects of curcumin MOLECULAR TARGETS AND THERAPEUTIC USES OF CURCUMIN IN HEALTH AND DISEASE. 2007; 595: 197-212	9	46	14	91
18245	18245 Silveira-Moriyama L, Holton JL, Kingsbury A, Ayling H, Sterlacci W, et al. The primary olfactory cortex in Parkinson's disease (PD) and incidental Lewy body disease (ILBD) MOVEMENT DISORDERS. 2007; 22: S91-S92	1	1	2	3
18246	18246 Olanow CW The pathogenesis of cell death in Parkinson's disease - 2007 MOVEMENT DISORDERS. 2007; 22: S335-S342	17	51	32	96
18247	18247 Gasser T Update on the genetics of Parkinson's disease MOVEMENT DISORDERS. 2007; 22: S343-S350	16	48	26	76
18248	18248 Caballol N, Marti MJ, Tolosa E Cognitive dysfunction and dementia in Parkinson disease MOVEMENT DISORDERS. 2007; 22: S358-S366	11	33	21	93
18249	18249 Altmann KH, Gertsch J Anticancer drugs from nature - natural products as a unique source of new microtubule-stabilizing agents NATURAL PRODUCT REPORTS. 2007; 24 (2): 327-357	1	68	3	372
18250	18250 Veitch NC Isoflavonoids of the Leguminosae NATURAL PRODUCT REPORTS. 2007; 24 (2): 417-464	0	30	1	406
#	Date / Author / Journal	LCS	GCS	LCR	CR
18251	18251 Ittner LM, Goetz J Pronuclear injection for the production of transgenic mice NATURE PROTOCOLS. 2007; 2 (5): 1206-1215	8	11	24	44
18252	18252 Reif A, Schmitt A, Fritzen S, Lesch KP Adult neurogenesis and schizophrenia: is there a link? NERVENHEILKUNDE. 2007; 26 (5): 368-+	0	2	13	141
18253	18253 Galert T, Schleim S Interference in the brain or attack on mental integrity? NERVENHEILKUNDE. 2007; 26 (7): 618-622	0	0	6	36
18254	18254 Wiltfang J, Bibl M, Maier M, Klafki H, Esselmann H, et al. Neurochemical early diagnostics and clinical neuro-proteomics of dementia disorders NERVENHEILKUNDE. 2007; 26 (10): 853-+	0	0	28	69
18255	18255 Morrison JH, Hof PR Life and death of neurons in the aging cerebral cortex NEUROBIOLOGY OF EPILEPSY AND AGING. 2007; 81: 41-+	6	23	9	69
18256	18256 Gnanapavan S, Giovannoni G Incorporation of other biomarkers NEURODEGENERATION IN MULTIPLE SCLEROSIS. 2007; : 183-207	0	0	42	146
18257	18257 Zacchetti D, Chieregatti E, Bettegazzi B, Mihailovich M, Sousa VL, et al. BACE1 expression and activity: Relevance in Alzheimer's disease NEURODEGENERATIVE DISEASES. 2007; 4 (2-3): 117-126	0	7	12	105
18258	18258 Herzig MC, Paganetti P, Staufenbiel M, Jucker M BACE1 and mutated presenilin-1 differently modulate A beta 40 and A beta 42 levels and cerebral amyloidosis in APPDutch transgenic mice NEURODEGENERATIVE DISEASES. 2007; 4 (2-3): 127-135	1	2	10	42
18259	18259 Lesage S, Leclere L, Lohmann E, Borg M, Ruberg M, et al. Frequency of the LRRK2 G2019S mutation in siblings with Parkinson's disease NEURODEGENERATIVE DISEASES. 2007; 4 (2-3): 195-198	1	4	8	28
18260	18260 Schmidt E, Seifert M, Baumeister R Caenorhabditis elegans as a model system for Parkinson's disease NEURODEGENERATIVE DISEASES. 2007; 4 (2-3): 199-217	3	8	34	110
#	Date / Author / Journal	LCS	GCS	LCR	CR
18261	18261 van der Zee J, Gijselinck I, Pirici D, Kumar-Singh S, Cruts M, et al. Frontotemporal lobar degeneration with ubiquitin-positive inclusions: A molecular genetic update NEURODEGENERATIVE DISEASES. 2007; 4 (2-3): 227-235	6	8	29	52
18262	18262 Gasparini L, Terni B, Spillantini MG Frontotemporal dementia with tau pathology NEURODEGENERATIVE DISEASES. 2007; 4 (2-3): 236-253	17	21	120	157
18263	18263 Herbst M, Wanker EE Small molecule inducers of heat-shock response reduce polyQ-Mediated huntingtin aggregation - A possible therapeutic strategy NEURODEGENERATIVE DISEASES. 2007; 4 (2-3): 254-260	6	19	12	37
18264	18264 Parish CL, Arenas E Stem-cell-based strategies for the treatment of Parkinson's disease NEURODEGENERATIVE DISEASES. 2007; 4 (4): 339-347	1	11	12	73
18265	18265 Mollenhauer B, Steinacker P, Bahn E, Bibl M, Brechlin P, et al. Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: Marker candidates for dementia with Lewy bodies NEURODEGENERATIVE DISEASES. 2007; 4 (5): 366-375	6	8	17	49
18266	18266 Sedaghat F, Gotzamani-Psarrakou A, Dedousi E, Arnaoutoglou M, Psarrakos K, et al. Evaluation of dopaminergic function in frontotemporal dementia using I- 123-FP-CIT single photon emission computed tomography NEURODEGENERATIVE DISEASES. 2007; 4 (5): 382-385	1	4	7	31
18267	18267 Irizarrya MC, Yao Y, Hyman BT, Growdon JH, Pratico D Plasma F2A lsoprostane levels in Alzheimer's and Parkinson's disease NEURODEGENERATIVE DISEASES. 2007; 4 (6): 403-405	10	12	11	17
18268	18268 Jellinger KA, Wenning GK, Seppi K Predictors of survival in dementia with Lewy bodies and Parkinson dementia NEURODEGENERATIVE DISEASES. 2007; 4 (6): 428-430	5	5	8	12
18269	18269 Fischer LR, Glass JD Axonal degeneration in motor neuron disease NEURODEGENERATIVE DISEASES. 2007; 4 (6): 431-442	6	25	26	136
18270	18270 Scarmeas N, Louis ED Mediterranean diet and essential tremor NEUROEPIDEMIOLOGY. 2007; 29 (3-4): 170-177	0	2	5	46
#	Date / Author / Journal	LCS	GCS	LCR	CR
18271	18271 Viviani B, Gardoni F, Marinovich M Cytokines and neuronal ion channels in health and disease NEUROINFLAMMATION IN NEURONAL DEATH AND REPAIR. 2007; 82: 247-263	0	34	2	85
18272	18272 Reynolds A, Laurie C, Mosley RL, Gendelman HE Oxidative stress and the pathogenesis of neurodegenerative disorders NEUROINFLAMMATION IN NEURONAL DEATH AND REPAIR. 2007; 82: 297-325	10	90	23	143
18273	18273 Szczudlik A, Rudzinska M Neuroprotective effect of dopomine agonists NEUROLOGIA I NEUROCHIRURGIA POLSKA. 2007; 41 (2): S22-S28	0	1	1	29
18274	18274 Mortiboys HJ, Schaefer J, Reichmann H, Jackson S Mitochondrial dysfunction in Parkinson's disease - revisited NEUROLOGIA I NEUROCHIRURGIA POLSKA. 2007; 41 (2): 150-159	1	5	22	118
18275	18275 Sulejczak D, Skup M Neurodegeneration in experimental stroke - involvement of apoptosis- regulating proteins NEUROLOGIA I NEUROCHIRURGIA POLSKA. 2007; 41 (6): 533-547	0	0	14	149
18276	18276 Petrik MS, Wilson JMB, Grant SC, Blackband SJ, Tabata RC, et al. Magnetic resonance microscopy and immunohistochemistry of the CNS of the mutant SOD murine model of ALS reveals widespread neural deficits NEUROMOLECULAR MEDICINE. 2007; 9 (3): 216-229	2	6	9	60
18277	18277 Yang J, Teng Q, Garrity-Moses ME, McClelland S, Federici T, et al. Reversible unilateral nigrostriatal pathway inhibition induced through expression of adenovirus-mediated clostridial light chain gene in the substantia nigra NEUROMOLECULAR MEDICINE. 2007; 9 (3): 276-284	0	0	4	39
18278	18278 Ransmayr G, Katzenschlager R, Dal-Bianco P, Wenning G, Bancher C, et al. Dementia with Lewy bodies and its differentiation from Alzheimer's disease NEUROPSYCHIATRIE. 2007; 21 (2): 63-74	3	4	12	42
18279	18279 Rogalski E, Blum D, Rademaker A, Weintraub S False recognition of incidentally learned pictures and words in primary progressive aphasia NEUROPSYCHOLOGIA. 2007; 45 (2): 368-377	4	5	6	48
18280	18280 Donohoe G, Morris DW, Clarke S, McGhee KA, Schwaiger S, et al. Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: A preliminary study NEUROPSYCHOLOGIA. 2007; 45 (2): 454-458	32	54	6	48
#	Date / Author / Journal	LCS	GCS	LCR	CR
18281	18281 Cotelli M, Borroni B, Manenti R, Ginex V, Calabria M, et al. Universal grammar in the frontotemporal dementia spectrum Evidence of a selective disorder in the corticobasal degeneration syndrome NEUROPSYCHOLOGIA. 2007; 45 (13): 3015-3023	0	2	19	59
18282	18282 Elmana LB, Grossman M Neuropsychiatric features of Amyotrophic Lateral Sclerosis NEUROREHABILITATION. 2007; 22 (6): 425-429	0	0	6	45
18283	18283 McCluskey L Amyotrophic Lateral Sclerosis: Ethical issues from diagnosis to end of life NEUROREHABILITATION. 2007; 22 (6): 463-472	1	4	6	112
18284	18284 O'Tuathaigh CMP, Babovic D, O'Meara G, Clifford JJ, Croke DT, et al. Susceptibility genes for schizophrenia: Characterisation of mutant mouse models at the level of phenotypic behaviour NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2007; 31 (1): 60-78	12	61	11	210
18285	18285 Gimenez-Llort L, Blazquez G, Canete T, Johansson B, Oddo S, et al. Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: A role for intraneuronal amyloid NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2007; 31 (1): 125-147	6	30	37	167
18286	18286 Lind NM, Moustgaard A, Jelsing J, Vajta G, Cumming P, et al. The use of pigs in neuroscience: Modeling brain disorders NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2007; 31 (5): 728-751	1	43	5	341
18287	18287 Gould TW, Oppenheim RW Synaptic dysfunction in disease and following injury in the developing and adult nervous system: Caveats in the choice of therapeutic intervention NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2007; 31 (8): 1073-1087	0	4	24	197
18288	18288 Trojanowski JQ, Lee VMY Microglial activation precedes tau pathology and neurodegeneration in a P301S mutant tau transgenic mouse NEUROSCIENCE RESEARCH. 2007; 58: S62-S62	0	0	0	0
18289	18289 Farkas O, Povlishock JT Cellular and subcellular change evoked by diffuse traumatic brain injury: a complex web of change extending far beyond focal damage NEUROTRAUMA: NEW INSIGHTS INTO PATHOLOGY AND TREATMENT. 2007; 161: 43-59	5	23	40	98
18290	18290 Floyd CL, Lyeth BG Astroglia: Important mediators of traumatic brain injury NEUROTRAUMA: NEW INSIGHTS INTO PATHOLOGY AND TREATMENT. 2007; 161: 61-79	2	15	12	188
#	Date / Author / Journal	LCS	GCS	LCR	CR
18291	18291 Kovesdi E, Czeiter E, Tamas A, Reglodi D, Szellar D, et al. Rescuing neurons and glia: is inhibition of apoptosis useful? NEUROTRAUMA: NEW INSIGHTS INTO PATHOLOGY AND TREATMENT. 2007; 161: 81-95	0	6	39	113
18292	18292 Bramlett HM, Dietrich WD Progressive damage after brain and spinal cord injury: pathomechanisms and treatment strategies NEUROTRAUMA: NEW INSIGHTS INTO PATHOLOGY AND TREATMENT. 2007; 161: 125-141	5	33	25	116
18293	18293 Weber JT Experimental models of repetitive brain injuries NEUROTRAUMA: NEW INSIGHTS INTO PATHOLOGY AND TREATMENT. 2007; 161: 253-261	4	11	13	48
18294	18294 Biasca N, Maxwell WL Minor traumatic brain injury in sports: a review in order to prevent neurological sequelae NEUROTRAUMA: NEW INSIGHTS INTO PATHOLOGY AND TREATMENT. 2007; 161: 263-291	1	7	16	146
18295	18295 Van Den Heuvel C, Thornton E, Vink R Traumatic brain injury and Alzheimer's disease: a review NEUROTRAUMA: NEW INSIGHTS INTO PATHOLOGY AND TREATMENT. 2007; 161: 303-316	11	29	39	121
18296	18296 Ottens AK, Kobeissy FH, Fuller BF, Liu MC, Oli MW, et al. Novel neuroproteomic approaches to studying traumatic brain injury NEUROTRAUMA: NEW INSIGHTS INTO PATHOLOGY AND TREATMENT. 2007; 161: 401-418	1	10	16	92
18297	18297 Deraeve C, Pitie M, Mazarguil H, Meunier B Bis-8-hydroxyquinoline ligands as potential anti-Alzheimer agents NEW JOURNAL OF CHEMISTRY. 2007; 31 (2): 193-195	3	10	9	20
18298	18298 Gijselinck I, Sleegers K, Engelborghs S, Robberecht W, Martin JJ, et al. Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS NEW TRENDS IN ALZHEIMER AND PARKINSON RELATED DISORDERS: ADPD 2007. 2007; : 1-11	0	0	21	42
18299	18299 Danzer KM, Karow AR, Hengerer B, Kostka M Alpha synuclein oligomers - The toxic species in Parkinson's disease? NEW TRENDS IN ALZHEIMER AND PARKINSON RELATED DISORDERS: ADPD 2007. 2007; : 217-224	0	0	8	19
18300	18300 Bonanni L, Thomas A, Monaco D, Baldassarre F, Onofrj M EEG comparisons in early AD, DLB, PDD patients with a 2 years follow-up NEW TRENDS IN ALZHEIMER AND PARKINSON RELATED DISORDERS: ADPD 2007. 2007; : 225-230	0	0	1	7

Date / Author / Journal

LCS

GCS

LCR

2007

18201

18201 Montalto MC, Farrar G, Hehir CT

Fibrillar and oligomeric beta-amyloid as distinct local biomarkers for Alzheimer's disease

IMAGING AND THE AGING BRAIN. 2007; 1097: 239-258

18202

18202 Thomale UW, Bender M, Casalis P, Rupprecht S, Griebenow M, et al.

Tacrolimus depresses local immune cell infiltration but fails to reduce cortical contusion volume in brain-injured rats

IMMUNOBIOLOGY. 2007; 212 (7): 567-576

18203

18203 Fletcher PT, Powell S, Foster NL, Joshi SC

Quantifying metabolic asymmetry modulo structure in Alzheimer's disease

INFORMATION PROCESSING IN MEDICAL IMAGING, PROCEEDINGS. 2007; 4584: 446-457

18204

18204 Gogos JA

Schizophrenia susceptibility genes: In search of a molecular logic and novel drug targets for a devastating disorder

INTEGRATING THE NEUROBIOLOGY OF SCHIZOPHRENIA. 2007; 78: 397-422

128

18205

18205 Ricchelli F, Fusi P, Tortora P, Valtorta M, Riva M, et al.

Destabilization of non-pathological variants of ataxin-3 by metal ions results in aggregation/fibrillogenesis

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. 2007; 39 (5): 966-977

18206

18206 Sode K, Ochiai S, Kobayashi N, Usuzaka E

Effect of reparation of repeat sequences in the human alpha-synuclein on fibrillation ability

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES. 2007; 3 (1): 1-7

18207

18207 Luo GR, Chen S, Le WD

Are heat shock proteins therapeutic target for Parkinson's disease?

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES. 2007; 3 (1): 20-26

18208

18208 Han NLR, Wen J, Lin QS, Tan PL, Liou YC, et al.

Proteomics analysis of the expression of neurogranin in murine neuroblastoma (Neuro-2a) cells reveals its involvement for cell differentiation

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES. 2007; 3 (5): 263-273

18209

18209 Tan U

The psychomotor theory of human mind

INTERNATIONAL JOURNAL OF NEUROSCIENCE. 2007; 117 (8): 1109-1148

134

18210

18210 Tarlac V, Turnbull V, Stefani D, Kelly L, Walsh R, et al.

Inclusion formation by ataxins-1,-2,-3, and-7

INTERNATIONAL JOURNAL OF NEUROSCIENCE. 2007; 117 (9): 1289-1314

Date / Author / Journal

LCS

GCS

LCR

18211

18211 Mariani E, Monastero R, Mecocci P

Mild cognitive impairment: A systematic review

JOURNAL OF ALZHEIMERS DISEASE. 2007; 12 (1): 23-35

130

18212

18212 Serretti A, Olgiati P, De Ronchi D

Genetics of Alzheimer's disease. A rapidly evolving field

JOURNAL OF ALZHEIMERS DISEASE. 2007; 12 (1): 73-92

298

18213

18213 Gruenblatt E, Zander N, Bartl J, Jie L, Monoranu CM, et al.

Comparison analysis of gene expression patterns between sporadic Alzheimer's and Parkinson's disease

JOURNAL OF ALZHEIMERS DISEASE. 2007; 12 (4): 291-311

18214

18214 Takshima A

Study of aluminum on the pathology of Alzheimer's disease: In vitro versus in vivo evidence

JOURNAL OF ALZHEIMERS DISEASE. 2007; 12 (4): 317-318

18215

18215 Barrantes A, Rejas MT, Benitez MJ, Jimenez JS

Interaction between Alzheimer's a beta 1-42 peptide and DNA detected by surface plasmon resonance

JOURNAL OF ALZHEIMERS DISEASE. 2007; 12 (4): 345-355

18216

18216 Luna-Munoz J, Chavez-Macias L, Garcia-Sierra F, Mena R

Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer's disease

JOURNAL OF ALZHEIMERS DISEASE. 2007; 12 (4): 365-375

18217

18217 Tremblay C, Pilote M, Phivilay A, Emond V, Bennett DA, et al.

Biochemical characterization of A beta and tau pathologies in mild cognitive impairment and Alzheimer's disease

JOURNAL OF ALZHEIMERS DISEASE. 2007; 12 (4): 377-390

18218

18218 Becker JS, Zoriy M, Becker JS, Dobrowolska J, Matusch A

Laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) in elemental imaging of biological tissues and in proteomicsw

JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY. 2007; 22 (7): 736-744

18219

18219 Becker JS, Przybylski M

Studies of structure and phosphorylation of tau protein using high resolution mass spectrometry

JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY. 2007; 22 (7): 761-765

18220

18220 Levy S, McConville M, Lazaro GA, Averback P

Competitive ELISA studies of neural thread protein in urine in Alzheimer's disease

JOURNAL OF CLINICAL LABORATORY ANALYSIS. 2007; 21 (1): 24-33

Date / Author / Journal

LCS

GCS

LCR

18221

18221 Matsuoka Y, Gray AJ, Hirata-Fukae C, Minami SS, Waterhouse EG, et al.

Intranasal NAP administration reduces accumulation of amyloid peptide and tau hyperphosphorylation in a transgenic mouse model of Alzheimer's disease at early pathological stage

JOURNAL OF MOLECULAR NEUROSCIENCE. 2007; 31 (2): 165-170

18222

18222 Musiek ES, McLaughlin B, Morrow JD

Electrophilic cyclopentenone isoprostanes in neurodegeneration

JOURNAL OF MOLECULAR NEUROSCIENCE. 2007; 33 (1): 80-86

18223

18223 Montine TJ, Quinn J, Kaye J, Morrow JD

F-2-isoprostanes as biomarkers of late-onset Alzheimer's disease

JOURNAL OF MOLECULAR NEUROSCIENCE. 2007; 33 (1): 114-119

18224

18224 Mollenhauer B, Bibl M, Esselmann H, Steinacker P, Trenkwalder C, et al.

Tauopathies and synucleinopathies: Do cerebrospinal fluid beta-amyloid peptides reflect disease-specific pathogenesis?

JOURNAL OF NEURAL TRANSMISSION. 2007; 114 (7): 919-927

18225

18225 Jellinger KA

Morphological substrates of parkinsonism with and without dementia: a retrospective clinico-pathological study

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2007; (72): 91-104

168

18226

18226 Offen D, Barhum Y, Levy YS, Burshtein A, Panet H, et al.

Intrastriatal transplantation of mouse bone marrow-derived stem cells improves motor behavior in a mouse model of Parkinson's disease

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2007; (72): 133-143

18227

18227 Muller N, Schwarz MJ

The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2007; (72): 269-280

120

18228

18228 Nudrnamud-Thanoi S, Piyabhan P, Harte MK, Cahir M, Reynolds GP

Deficits of neuronal glutamatergic markers in the caudate nucleus in schizophrenia

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2007; (72): 281-285

18229

18229 Schwartz L, Civitello L, Dunn-Pirio A, Ryschkewitsch S, Berry E, et al.

Evidence of human immunodeficiency virus type 1 infection of nestin- positive neural progenitors in archival pediatric brain tissue

JOURNAL OF NEUROVIROLOGY. 2007; 13 (3): 274-283

18230

18230 Cueille N, Blanc CT, Riederer IM, Riederer BM

Microtubule-associated protein 1B binds glyceraldehyde-3-phosphate dehydrogenase

JOURNAL OF PROTEOME RESEARCH. 2007; 6 (7): 2640-2647

Date / Author / Journal

LCS

GCS

LCR

18231

18231 Krewski D, Yokel RA, Nieboer E, Borchelt D, Cohen J, et al.

Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide

JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS. 2007; 10: 1-269

1515

18232

18232 Hachiya NS, Kaneko K

Investigation of laser-micro dissected inclusion bodies

LASER MANIPULATION OF CELLS AND TISSUES. 2007; 82: 355-375

18233

18233 Barbas H

Specialized elements of orbitofrontal cortex in primates

LINKING AFFECT TO ACTION: CRITICAL CONTRIBUTIONS OF THE ORBITOFRONTAL CORTEX. 2007; 1121: 10-32

119

18234

18234 Viskontas IV, Possin KL, Miller BL

Symptoms of frontotemporal dementia provide insights into orbitofrontal cortex function and social behavior

LINKING AFFECT TO ACTION: CRITICAL CONTRIBUTIONS OF THE ORBITOFRONTAL CORTEX. 2007; 1121: 528-545

18235

18235 Dhikav V, Anand KS

Glucocorticoids may initiate Alzheimer's disease: A Potential therapeutic role for mifepristone (RU-486)

MEDICAL HYPOTHESES. 2007; 68 (5): 1088-1092

18236

18236 Pedersen AE

The potential for induction of autoimmune disease by a randomly-mutated self-antigen

MEDICAL HYPOTHESES. 2007; 68 (6): 1240-1246

18237

18237 Stommel EW, Graber D, Montanye J, Cohen JA, Harris BT

Does treating schizophrenia reduce the chances of developing amyotrophic lateral sclerosis?

MEDICAL HYPOTHESES. 2007; 69 (5): 1021-1028

108

18238

18238 Chaudhuri A, Hollands P, Bhattacharya N

Placental umbilical cord blood transfusion in acute ischaemic stroke

MEDICAL HYPOTHESES. 2007; 69 (6): 1267-1271

18239

18239 Cacabelos R

Molecular pathology and pharmacogenomics in Alzheimer's disease: Polygenic-related effects of multifactorial treatments on cognition, anxiety, and depression

METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY. 2007; 29: 1-91

100

677

18240

18240 Brignull HR, Morley JF, Morimoto RI

The stress of misfolded proteins: C-elegans models for neurodegenerative disease and aging

MOLECULAR ASPECTS OF THE STRESS RESPONSE: CHAPERONES, MEMBRANES AND NETWORKS. 2007; 594: 167-189

104

Date / Author / Journal

LCS

GCS

LCR

18241

18241 Rankin CA, Sun Q, Gamblin TC

Tau phosphorylation by GSK-3 beta promotes tangle-like filament morphology

MOLECULAR NEURODEGENERATION. 2007; 2: Art. No. 12

18242

18242 Casadesus G, Smith MA, Basu S, Hua J, Capobianco DE, et al.

Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer disease

MOLECULAR NEURODEGENERATION. 2007; 2: Art. No. 2

18243

18243 Gu XF, Andre VM, Cepeda C, Li SH, Li XJ, et al.

Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease

MOLECULAR NEURODEGENERATION. 2007; 2: Art. No. 8

18244

18244 Cole GM, Teter B, Frautschy SA

Neuroprotective effects of curcumin

MOLECULAR TARGETS AND THERAPEUTIC USES OF CURCUMIN IN HEALTH AND DISEASE. 2007; 595: 197-212

18245

18245 Silveira-Moriyama L, Holton JL, Kingsbury A, Ayling H, Sterlacci W, et al.

The primary olfactory cortex in Parkinson's disease (PD) and incidental Lewy body disease (ILBD)

MOVEMENT DISORDERS. 2007; 22: S91-S92

18246

18246 Olanow CW

The pathogenesis of cell death in Parkinson's disease - 2007

MOVEMENT DISORDERS. 2007; 22: S335-S342

18247

18247 Gasser T

Update on the genetics of Parkinson's disease

MOVEMENT DISORDERS. 2007; 22: S343-S350

18248

18248 Caballol N, Marti MJ, Tolosa E

Cognitive dysfunction and dementia in Parkinson disease

MOVEMENT DISORDERS. 2007; 22: S358-S366

18249

18249 Altmann KH, Gertsch J

Anticancer drugs from nature - natural products as a unique source of new microtubule-stabilizing agents

NATURAL PRODUCT REPORTS. 2007; 24 (2): 327-357

372

18250

18250 Veitch NC

Isoflavonoids of the Leguminosae

NATURAL PRODUCT REPORTS. 2007; 24 (2): 417-464

406

Date / Author / Journal

LCS

GCS

LCR

18251

18251 Ittner LM, Goetz J

Pronuclear injection for the production of transgenic mice

NATURE PROTOCOLS. 2007; 2 (5): 1206-1215

18252

18252 Reif A, Schmitt A, Fritzen S, Lesch KP

Adult neurogenesis and schizophrenia: is there a link?

NERVENHEILKUNDE. 2007; 26 (5): 368-+

141

18253

18253 Galert T, Schleim S

Interference in the brain or attack on mental integrity?

NERVENHEILKUNDE. 2007; 26 (7): 618-622

18254

18254 Wiltfang J, Bibl M, Maier M, Klafki H, Esselmann H, et al.

Neurochemical early diagnostics and clinical neuro-proteomics of dementia disorders

NERVENHEILKUNDE. 2007; 26 (10): 853-+

18255

18255 Morrison JH, Hof PR

Life and death of neurons in the aging cerebral cortex

NEUROBIOLOGY OF EPILEPSY AND AGING. 2007; 81: 41-+

18256

18256 Gnanapavan S, Giovannoni G

Incorporation of other biomarkers

NEURODEGENERATION IN MULTIPLE SCLEROSIS. 2007; : 183-207

146

18257

18257 Zacchetti D, Chieregatti E, Bettegazzi B, Mihailovich M, Sousa VL, et al.

BACE1 expression and activity: Relevance in Alzheimer's disease

NEURODEGENERATIVE DISEASES. 2007; 4 (2-3): 117-126

105

18258

18258 Herzig MC, Paganetti P, Staufenbiel M, Jucker M

BACE1 and mutated presenilin-1 differently modulate A beta 40 and A beta 42 levels and cerebral amyloidosis in APPDutch transgenic mice

NEURODEGENERATIVE DISEASES. 2007; 4 (2-3): 127-135

18259

18259 Lesage S, Leclere L, Lohmann E, Borg M, Ruberg M, et al.

Frequency of the LRRK2 G2019S mutation in siblings with Parkinson's disease

NEURODEGENERATIVE DISEASES. 2007; 4 (2-3): 195-198

18260

18260 Schmidt E, Seifert M, Baumeister R

Caenorhabditis elegans as a model system for Parkinson's disease

NEURODEGENERATIVE DISEASES. 2007; 4 (2-3): 199-217

110

Date / Author / Journal

LCS

GCS

LCR

18261

18261 van der Zee J, Gijselinck I, Pirici D, Kumar-Singh S, Cruts M, et al.

Frontotemporal lobar degeneration with ubiquitin-positive inclusions: A molecular genetic update

NEURODEGENERATIVE DISEASES. 2007; 4 (2-3): 227-235

18262

18262 Gasparini L, Terni B, Spillantini MG

Frontotemporal dementia with tau pathology

NEURODEGENERATIVE DISEASES. 2007; 4 (2-3): 236-253

120

157

18263

18263 Herbst M, Wanker EE

Small molecule inducers of heat-shock response reduce polyQ-Mediated huntingtin aggregation - A possible therapeutic strategy

NEURODEGENERATIVE DISEASES. 2007; 4 (2-3): 254-260

18264

18264 Parish CL, Arenas E

Stem-cell-based strategies for the treatment of Parkinson's disease

NEURODEGENERATIVE DISEASES. 2007; 4 (4): 339-347

18265

18265 Mollenhauer B, Steinacker P, Bahn E, Bibl M, Brechlin P, et al.

Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: Marker candidates for dementia with Lewy bodies

NEURODEGENERATIVE DISEASES. 2007; 4 (5): 366-375

18266

18266 Sedaghat F, Gotzamani-Psarrakou A, Dedousi E, Arnaoutoglou M, Psarrakos K, et al.

Evaluation of dopaminergic function in frontotemporal dementia using I- 123-FP-CIT single photon emission computed tomography

NEURODEGENERATIVE DISEASES. 2007; 4 (5): 382-385

18267

18267 Irizarrya MC, Yao Y, Hyman BT, Growdon JH, Pratico D

Plasma F2A lsoprostane levels in Alzheimer's and Parkinson's disease

NEURODEGENERATIVE DISEASES. 2007; 4 (6): 403-405

18268

18268 Jellinger KA, Wenning GK, Seppi K

Predictors of survival in dementia with Lewy bodies and Parkinson dementia

NEURODEGENERATIVE DISEASES. 2007; 4 (6): 428-430

18269

18269 Fischer LR, Glass JD

Axonal degeneration in motor neuron disease

NEURODEGENERATIVE DISEASES. 2007; 4 (6): 431-442

136

18270

18270 Scarmeas N, Louis ED

Mediterranean diet and essential tremor

NEUROEPIDEMIOLOGY. 2007; 29 (3-4): 170-177

Date / Author / Journal

LCS

GCS

LCR

18271

18271 Viviani B, Gardoni F, Marinovich M

Cytokines and neuronal ion channels in health and disease

NEUROINFLAMMATION IN NEURONAL DEATH AND REPAIR. 2007; 82: 247-263

18272

18272 Reynolds A, Laurie C, Mosley RL, Gendelman HE

Oxidative stress and the pathogenesis of neurodegenerative disorders

NEUROINFLAMMATION IN NEURONAL DEATH AND REPAIR. 2007; 82: 297-325

143

18273

18273 Szczudlik A, Rudzinska M

Neuroprotective effect of dopomine agonists

NEUROLOGIA I NEUROCHIRURGIA POLSKA. 2007; 41 (2): S22-S28

18274

18274 Mortiboys HJ, Schaefer J, Reichmann H, Jackson S

Mitochondrial dysfunction in Parkinson's disease - revisited

NEUROLOGIA I NEUROCHIRURGIA POLSKA. 2007; 41 (2): 150-159

118

18275

18275 Sulejczak D, Skup M

Neurodegeneration in experimental stroke - involvement of apoptosis- regulating proteins

NEUROLOGIA I NEUROCHIRURGIA POLSKA. 2007; 41 (6): 533-547

149

18276

18276 Petrik MS, Wilson JMB, Grant SC, Blackband SJ, Tabata RC, et al.

Magnetic resonance microscopy and immunohistochemistry of the CNS of the mutant SOD murine model of ALS reveals widespread neural deficits

NEUROMOLECULAR MEDICINE. 2007; 9 (3): 216-229

18277

18277 Yang J, Teng Q, Garrity-Moses ME, McClelland S, Federici T, et al.

Reversible unilateral nigrostriatal pathway inhibition induced through expression of adenovirus-mediated clostridial light chain gene in the substantia nigra

NEUROMOLECULAR MEDICINE. 2007; 9 (3): 276-284

18278

18278 Ransmayr G, Katzenschlager R, Dal-Bianco P, Wenning G, Bancher C, et al.

Dementia with Lewy bodies and its differentiation from Alzheimer's disease

NEUROPSYCHIATRIE. 2007; 21 (2): 63-74

18279

18279 Rogalski E, Blum D, Rademaker A, Weintraub S

False recognition of incidentally learned pictures and words in primary progressive aphasia

NEUROPSYCHOLOGIA. 2007; 45 (2): 368-377

18280

18280 Donohoe G, Morris DW, Clarke S, McGhee KA, Schwaiger S, et al.

Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: A preliminary study

NEUROPSYCHOLOGIA. 2007; 45 (2): 454-458

Date / Author / Journal

LCS

GCS

LCR

18281

18281 Cotelli M, Borroni B, Manenti R, Ginex V, Calabria M, et al.

Universal grammar in the frontotemporal dementia spectrum Evidence of a selective disorder in the corticobasal degeneration syndrome

NEUROPSYCHOLOGIA. 2007; 45 (13): 3015-3023

18282

18282 Elmana LB, Grossman M

Neuropsychiatric features of Amyotrophic Lateral Sclerosis

NEUROREHABILITATION. 2007; 22 (6): 425-429

18283

18283 McCluskey L

Amyotrophic Lateral Sclerosis: Ethical issues from diagnosis to end of life

NEUROREHABILITATION. 2007; 22 (6): 463-472

112

18284

18284 O'Tuathaigh CMP, Babovic D, O'Meara G, Clifford JJ, Croke DT, et al.

Susceptibility genes for schizophrenia: Characterisation of mutant mouse models at the level of phenotypic behaviour

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2007; 31 (1): 60-78

210

18285

18285 Gimenez-Llort L, Blazquez G, Canete T, Johansson B, Oddo S, et al.

Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: A role for intraneuronal amyloid

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2007; 31 (1): 125-147

167

18286

18286 Lind NM, Moustgaard A, Jelsing J, Vajta G, Cumming P, et al.

The use of pigs in neuroscience: Modeling brain disorders

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2007; 31 (5): 728-751

341

18287

18287 Gould TW, Oppenheim RW

Synaptic dysfunction in disease and following injury in the developing and adult nervous system: Caveats in the choice of therapeutic intervention

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2007; 31 (8): 1073-1087

197

18288

18288 Trojanowski JQ, Lee VMY

Microglial activation precedes tau pathology and neurodegeneration in a P301S mutant tau transgenic mouse

NEUROSCIENCE RESEARCH. 2007; 58: S62-S62

18289

18289 Farkas O, Povlishock JT

Cellular and subcellular change evoked by diffuse traumatic brain injury: a complex web of change extending far beyond focal damage

NEUROTRAUMA: NEW INSIGHTS INTO PATHOLOGY AND TREATMENT. 2007; 161: 43-59

18290

18290 Floyd CL, Lyeth BG

Astroglia: Important mediators of traumatic brain injury

NEUROTRAUMA: NEW INSIGHTS INTO PATHOLOGY AND TREATMENT. 2007; 161: 61-79

188

Date / Author / Journal

LCS

GCS

LCR

18291

18291 Kovesdi E, Czeiter E, Tamas A, Reglodi D, Szellar D, et al.

Rescuing neurons and glia: is inhibition of apoptosis useful?

NEUROTRAUMA: NEW INSIGHTS INTO PATHOLOGY AND TREATMENT. 2007; 161: 81-95

113

18292

18292 Bramlett HM, Dietrich WD

Progressive damage after brain and spinal cord injury: pathomechanisms and treatment strategies

NEUROTRAUMA: NEW INSIGHTS INTO PATHOLOGY AND TREATMENT. 2007; 161: 125-141

116

18293

18293 Weber JT

Experimental models of repetitive brain injuries

NEUROTRAUMA: NEW INSIGHTS INTO PATHOLOGY AND TREATMENT. 2007; 161: 253-261

18294

18294 Biasca N, Maxwell WL

Minor traumatic brain injury in sports: a review in order to prevent neurological sequelae

NEUROTRAUMA: NEW INSIGHTS INTO PATHOLOGY AND TREATMENT. 2007; 161: 263-291

146

18295

18295 Van Den Heuvel C, Thornton E, Vink R

Traumatic brain injury and Alzheimer's disease: a review

NEUROTRAUMA: NEW INSIGHTS INTO PATHOLOGY AND TREATMENT. 2007; 161: 303-316

121

18296

18296 Ottens AK, Kobeissy FH, Fuller BF, Liu MC, Oli MW, et al.

Novel neuroproteomic approaches to studying traumatic brain injury

NEUROTRAUMA: NEW INSIGHTS INTO PATHOLOGY AND TREATMENT. 2007; 161: 401-418

18297

18297 Deraeve C, Pitie M, Mazarguil H, Meunier B

Bis-8-hydroxyquinoline ligands as potential anti-Alzheimer agents

NEW JOURNAL OF CHEMISTRY. 2007; 31 (2): 193-195

18298

18298 Gijselinck I, Sleegers K, Engelborghs S, Robberecht W, Martin JJ, et al.

Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS

NEW TRENDS IN ALZHEIMER AND PARKINSON RELATED DISORDERS: ADPD 2007. 2007; : 1-11

18299

18299 Danzer KM, Karow AR, Hengerer B, Kostka M

Alpha synuclein oligomers - The toxic species in Parkinson's disease?

NEW TRENDS IN ALZHEIMER AND PARKINSON RELATED DISORDERS: ADPD 2007. 2007; : 217-224

18300

18300 Bonanni L, Thomas A, Monaco D, Baldassarre F, Onofrj M

EEG comparisons in early AD, DLB, PDD patients with a 2 years follow-up

NEW TRENDS IN ALZHEIMER AND PARKINSON RELATED DISORDERS: ADPD 2007. 2007; : 225-230

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records